Stock listing
Dusseldorf:DMP Dermapharm Holding SE Aktie
German listing (Dusseldorf) of Dermapharm Holding SE · home listing Xetra:DMP
Follow Dermapharm Holding SE into a list and get an email when it puts out news.
Share price · DUS:DMP
€32.80 EUR -0.50 (-1.5%)
Close on Nov 20, 2026
- Day range
- €32.55 – €33.15 EURNov 20, 2026
- Market cap
- €3.79B EURAt the close on Nov 20, 2026 · price × 115.4M shares outstanding
- 52-week range
- €32.55 – €50.78 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €2 EURMedian day 0 shares · 56 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Xetra:DMP · Home | €32.75 EUR | -1.30 (-3.8%) | 42,627 | €32.95 | €33.45 | €32.75 | €34.05 | Close on Nov 20, 2026 |
| OTC:DMPHF | $38.84 USD | -8.85 (-18.6%) | 200 | $38.84 | $38.84 | $38.84 | $47.69 | Close on Nov 13, 2026 |
| Dusseldorf:DMP | €32.80 EUR | -0.50 (-1.5%) | — | €32.55 | €33.15 | €32.55 | €33.30 | Close on Nov 20, 2026 |
| Hamburg:DMP | €33.30 EUR | -0.60 (-1.8%) | 120 | €32.55 | €33.30 | €32.55 | €33.90 | Close on Nov 20, 2026 |
| Munich:DMP | €32.95 EUR | -1.40 (-4.1%) | — | €32.95 | €32.95 | €32.95 | €34.35 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · DUS:DMP · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €37.93 | -0.659 | -1.7% | €37.99 | €38.10 | €37.88 | 0 | |
| €38.58 | +0.241 | +0.6% | €38.76 | €39.46 | €38.28 | 0 | |
| €38.34 | -0.049 | -0.1% | €38.27 | €38.36 | €38.10 | 0 | |
| €38.39 | -0.285 | -0.7% | €39.12 | €39.35 | €37.86 | 0 | |
| €38.68 | +0.195 | +0.5% | €38.73 | €38.75 | €38.68 | 0 | |
| €38.48 | +0.206 | +0.5% | €38.53 | €38.56 | €38.22 | 0 | |
| €38.28 | -0.102 | -0.3% | €38.24 | €38.28 | €38.20 | 0 | |
| €38.38 | +0.569 | +1.5% | €38.53 | €38.65 | €38.06 | 0 | |
| €37.81 | -0.373 | -1.0% | €38.01 | €38.09 | €37.74 | 0 | |
| €38.18 | -0.312 | -0.8% | €38.34 | €38.50 | €37.93 | 0 | |
| €38.49 | -0.206 | -0.5% | €38.55 | €38.55 | €38.39 | 0 | |
| €38.70 | +0.505 | +1.3% | €38.81 | €38.91 | €38.54 | 0 | |
| €38.20 | +0.109 | +0.3% | €38.47 | €38.55 | €38.20 | 0 | |
| €38.09 | +0.353 | +0.9% | €37.46 | €38.43 | €37.37 | 0 | |
| €37.73 | -0.058 | -0.2% | €37.76 | €37.89 | €37.73 | 0 | |
| €37.79 | -0.433 | -1.1% | €37.94 | €38.01 | €37.62 | 0 | |
| €38.22 | +0.355 | +0.9% | €38.28 | €38.59 | €37.84 | 0 | |
| €37.87 | +0.039 | +0.1% | €37.81 | €38.76 | €37.76 | 0 | |
| €37.83 | -0.267 | -0.7% | €37.88 | €37.94 | €37.54 | 0 | |
| €38.10 | -0.251 | -0.7% | €38.23 | €38.23 | €38.02 | 0 | |
| €38.35 | +0.619 | +1.6% | €38.36 | €38.36 | €38.28 | 0 | |
| €37.73 | -0.735 | -1.9% | €38.56 | €38.67 | €37.62 | 0 | |
| €38.46 | +0.545 | +1.4% | €38.35 | €38.62 | €38.15 | 0 | |
| €37.92 | +0.527 | +1.4% | €37.57 | €37.94 | €37.47 | 0 | |
| €37.39 | -0.147 | -0.4% | €37.47 | €37.50 | €37.28 | 0 | |
| €37.54 | -0.516 | -1.4% | €38.21 | €38.49 | €37.52 | 0 | |
| €38.06 | -1.102 | -2.8% | €38.60 | €38.65 | €37.77 | 0 | |
| €39.16 | +0.275 | +0.7% | €38.76 | €39.47 | €38.59 | 0 | |
| €38.88 | -0.201 | -0.5% | €39.29 | €39.61 | €38.80 | 0 | |
| €39.08 | +0.039 | +0.1% | €39.04 | €39.63 | €38.80 | 0 | |
| €39.04 | -0.408 | -1.0% | €39.11 | €39.11 | €38.50 | 0 | |
| €39.45 | +0.631 | +1.6% | €38.68 | €39.68 | €38.67 | 0 | |
| €38.82 | -0.704 | -1.8% | €39.75 | €39.77 | €38.59 | 0 | |
| €39.53 | +0.706 | +1.8% | €38.67 | €39.55 | €38.55 | 0 | |
| €38.82 | -0.029 | -0.1% | €38.83 | €38.96 | €38.82 | 0 | |
| €38.85 | +0.10 | +0.3% | €38.95 | €39.03 | €38.35 | 0 | |
| €38.75 | +0.654 | +1.7% | €38.85 | €39.35 | €38.30 | 0 | |
| €38.09 | +0.312 | +0.8% | €37.41 | €38.41 | €37.35 | 0 | |
| €37.78 | +0.364 | +1.0% | €37.81 | €37.81 | €37.62 | 0 | |
| €37.42 | -0.226 | -0.6% | €37.41 | €37.55 | €37.27 | 0 | |
| €37.64 | -0.436 | -1.1% | €38.36 | €38.43 | €37.58 | 0 | |
| €38.08 | -0.711 | -1.8% | €38.47 | €38.59 | €37.62 | 0 | |
| €38.79 | +0.648 | +1.7% | €38.80 | €38.82 | €38.78 | 0 | |
| €38.14 | -1.559 | -3.9% | €38.39 | €38.42 | €38.14 | 0 | |
| €39.70 | +0.596 | +1.5% | €39.70 | €39.70 | €39.70 | 3 | |
| €39.11 | +0.672 | +1.7% | €38.80 | €39.26 | €38.63 | 0 | |
| €38.43 | +0.364 | +1.0% | €38.37 | €39.13 | €38.35 | 0 | |
| €38.07 | -0.779 | -2.0% | €38.61 | €39.13 | €37.84 | 0 | |
| €38.85 | +0.008 | 0.0% | €38.87 | €38.88 | €38.70 | 0 | |
| €38.84 | -0.53 | -1.3% | €39.27 | €39.72 | €38.82 | 0 | |
| €39.37 | -0.493 | -1.2% | €39.73 | €39.91 | €39.23 | 0 | |
| €39.86 | -0.141 | -0.4% | €39.96 | €40.01 | €39.43 | 0 | |
| €40.01 | -1.465 | -3.5% | €41.65 | €41.90 | €39.83 | 0 | |
| €41.47 | +2.137 | +5.4% | €40.12 | €42.13 | €39.91 | 0 | |
| €39.33 | -0.166 | -0.4% | €40.11 | €40.26 | €39.11 | 0 | |
| €39.50 | -0.173 | -0.4% | €39.50 | €39.51 | €39.50 | 0 | |
| €39.67 | -0.349 | -0.9% | €39.81 | €39.93 | €39.57 | 0 |
- Ticker
- Dusseldorf:DMP
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- Dusseldorf
- Currency
- EUR
What changed lately
Latest news release · Aug 25, 2026
Dermapharm confirms profitable growth in H1 2026 and increases adjusted EBITDA
Latest earnings call · Aug 25, 2026
Dermapharm Holding (Xetra:DMP) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Nov 12, 2026
Dermapharm Hldg — Q3 2026 Earnings Presentation
Earnings · 24 slides
Latest news
Dermapharm confirms profitable growth in H1 2026 and increases adjusted EBITDA
Aug 25, 2026
Closed €41.47 (+5.4%) on Aug 25, 2026
Dermapharm Holding SE reports profitable growth in H1 2026 and confirms guidance
Aug 11, 2026
Closed €40.13 (+0.5%) on Aug 11, 2026
Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share
Jun 26, 2026
Closed €47.40 (+2.9%) on Jun 26, 2026
Dermapharm Holding SE performs in line with projections in Q1 2026 and confirms guidance
May 13, 2026
Closed €46.36 (+0.9%) on May 13, 2026
Dermapharm Holding SE reports dip in revenue, rise in adjusted consolidated EBITDA and margin
Mar 31, 2026
Closed €41.91 (-2.8%) on Mar 31, 2026
Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Mar 26, 2026
Closed €42.08 (-3.7%) on Mar 27, 2026
Dermapharm Holding SE resolves public share buyback offer for up to 4,300,000 shares
Mar 10, 2026
Closed €40.60 (+7.4%) on Mar 10, 2026
Dermapharm Holding SE records decline in consolidated revenue, adjusted consolidated EBITDA improves
Mar 10, 2026
Closed €40.60 (+7.4%) on Mar 10, 2026
Dermapharm Holding SE on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 8 in the last 12 months · 10 in all · newest Aug 25, 2026 · oldest 2025
- Calls
- 1 call with a replay · 1 with a transcript · latest Aug 25, 2026
- Decks
- 51 decks · latest Nov 12, 2026
Where Dermapharm Holding SE is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Xetra:DMP · Home listing | Xetra | Germany | EUR |
| Tradegate:DMP | Tradegate | Germany | EUR |
| gettex:DMP | gettex | Germany | EUR |
| Stuttgart:DMP | Stuttgart | Germany | EUR |
| LS Exchange:A2GS5D | LS Exchange | Germany | EUR |
| LSIN:0A5J | LSIN | United Kingdom | EUR |
| OTC:DMPHF | OTC | United States | USD |
| Frankfurt:DMP | Frankfurt | Germany | EUR |
| Hanover:DMP | Hanover | Germany | EUR |
| Lang & Schwarz:A2GS5D | Lang & Schwarz | Germany | EUR |
| BX Swiss:DMP | BX Swiss | Switzerland | CHF |
| Dusseldorf:DMP · This page | Dusseldorf | Germany | EUR |
| Hamburg:DMP | Hamburg | Germany | EUR |
| Munich:DMP | Munich | Germany | EUR |
| Aquis:DMPD | Aquis | United Kingdom | EUR |
| VIE:DMP | Vienna | Austria | EUR |
| Aquis:DMPD | Aquis | United Kingdom | EUR |
| Turquoise:DMPD | Turquoise | United Kingdom | EUR |
Valuation
P/E 12.4× against a median of 19.1×: 3rd lowest of 10 Pharmaceuticals companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- €2.62B EUR
- P/E
- 12.4×
- EV/sales
- 2.2×
- EV/EBITDA
- 6.9×
- Price/book
- 2.9×
- Gross margin
- 33.8%
- Operating margin
- 20.9%
- Net margin
- 11.1%
- Debt to equity
- 2.0×
- Beta
- No index for this market yet
Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Dermapharm Holding SE · XETR:DMP | US$1.78B | US$2.88B | 12.4× | 2.2× | 6.9× | 2.9× | 11.1% | 2.0× | n/a |
| Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A · SSE:603707 | US$1.90B | US$1.52B | 29.8× | 2.5× | n/a | 1.8× | 10.4% | 0.0× | n/a |
| Shenzhen Kangtai Biological Products Co. Ltd. Class A · SZSE:300601 | US$1.80B | US$1.74B | 103× | 4.7× | n/a | 1.2× | 4.8% | 0.2× | n/a |
| Shilpa Medicare Limited · NSE:SHILPAMED | US$1.79B | US$1.85B | 50.0× | 9.3× | 33.5× | 6.0× | 18.1% | 0.2× | n/a |
| Shenyang Xingqi Pharmaceutical Co., Ltd. Class A · SZSE:300573 | US$1.76B | US$1.69B | 14.6× | 4.0× | n/a | 5.2× | 28.6% | 0.0× | n/a |
| Eton Pharmaceuticals, Inc. · NASDAQ:ETON | US$1.76B | US$1.71B | 35.2× | 12.1× | 38.7× | 20.2× | 35.4% | 0.1× | 0.57 |
| United Laboratories International Holdings Ltd. · HKEX:3933 | US$1.73B | US$863.1M | 5.5× | 0.4× | 2.0× | 0.7× | 15.8% | 0.3× | n/a |
| H. Lundbeck A/S Class A · OMXCOP:HLUN_A | US$1.71B | US$2.45B | 2.9× | 0.6× | 1.7× | 0.4× | 15.5% | 0.3× | n/a |
| Harbin Pharmaceutical Group Co., Ltd. Class A · SSE:600664 | US$1.70B | US$1.22B | 17.9× | 0.5× | n/a | 1.8× | 3.9% | 0.0× | n/a |
| Mayinglong Pharmaceutical Group Co., Ltd. Class A · SSE:600993 | US$1.70B | US$1.34B | 19.1× | 2.2× | n/a | 2.5× | 14.9% | 0.0× | n/a |
| Ultragenyx Pharmaceutical Inc. · NASDAQ:RARE | US$1.68B | US$2.60B | n/a | 3.6× | n/a | n/a | −71.8% | n/a | 1.35 |
| Median of the others | US$1.74B | US$1.70B | 19.1× | 3.0× | 17.7× | 1.8× | 15.2% | 0.1× | 0.96 |
Forecasts
Analysts' consensus from EODHD, read Nov 14, 2026. Not 6ix's view and not investment advice.
- Price target
- 51.00 EUR · Analysts' mean
- EPS, year to Dec 2026
- 2.53 · 1 analyst
- Revenue, year to Dec 2026
- 1.19B · 3 analysts
Team and board
| Officer | Role |
|---|---|
| Britta Hamberger | Investor Relations & Corporate Communications |
| Dermapharm Holding SE | ir.dermapharm.de |
Events
Calls
| Call | When | Status |
|---|---|---|
| Dermapharm Holding (Xetra:DMP) Q2 2026 Earnings Call | Tue, Aug 25, 2026 · 8:00 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 12, 2026 · After close | +0.9% |
| Q2 2026 | Aug 25, 2026 · After close | −4.6% |
| Q1 2026 | May 13, 2026 · After close | +7.7% |
| Q4 2025 | Mar 30, 2026 · After close | −3.6% |
| Q3 2025 | Nov 13, 2025 · After close | +2.2% |
| Q2 2025 | Aug 26, 2025 · After close | +1.2% |
| Q1 2025 | May 15, 2025 · Before open | −8.7% |
| Q4 2024 | Mar 14, 2025 | +11.3% |
| Q3 2024 | Nov 14, 2024 · Before open | +8.6% |
| Q2 2024 | Aug 27, 2024 · Before open | −2.0% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 15, 2024 · Before open | +3.3% |
| Q4 2023 | Mar 28, 2024 · Before open | −4.5% |
| Q3 2023 | Nov 15, 2023 · Before open | +0.6% |
| Q2 2023 | Aug 16, 2023 · Before open | +12.8% |
| Q1 2023 | May 15, 2023 · Before open | +8.0% |
| Q4 2022 | Mar 28, 2023 · Before open | +0.6% |
| Q3 2022 | Nov 16, 2022 · Before open | +2.5% |
| Q2 2022 | Sep 7, 2022 · Before open | −3.3% |
| Q1 2022 | May 18, 2022 · Before open | −13.4% |
| Quarter to Sep 30, 2021 | Nov 16, 2021 | −6.1% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Dermapharm Hldg — Q3 2026 Earnings Presentation | Earnings | 24 slides | Nov 12, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 21 slides | May 13, 2026 |
| FY2025 Earnings Presentation | Earnings | 24 slides | Mar 31, 2026 |
| Fact Sheet (2026) | Fact sheet | 2 slides | Mar 30, 2026 |
| Fact Sheet (December 2025) | Fact sheet | 2 slides | Dec 31, 2025 |
| Q3 2025 Earnings Presentation | Earnings | 23 slides | Nov 13, 2025 |
| H1 2025 Earnings Presentation | Earnings | 23 slides | Aug 26, 2025 |
| Fact Sheet (June 2025) | Fact sheet | 2 slides | Jun 30, 2025 |
| Shareholder Meeting (June 2025) | Shareholder meeting | 15 slides | Jun 26, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 22 slides | May 15, 2025 |
Show 50 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| FY2024 Earnings Presentation | Earnings | 24 slides | Mar 28, 2025 |
| Q3 2024 Earnings Presentation | Earnings | 23 slides | Nov 14, 2024 |
| Fact Sheet (November 2024) | Fact sheet | 2 slides | November 2024 |
| H1 2024 Earnings Presentation | Earnings | 22 slides | Aug 27, 2024 |
| Fact Sheet (June 2024) | Fact sheet | 2 slides | Jun 30, 2024 |
| Q1 2024 Earnings Presentation | Earnings | 20 slides | May 15, 2024 |
| Fact Sheet (March 2024) | Fact sheet | 2 slides | March 2024 |
| Fact Sheet (March 2024) | Fact sheet | 2 slides | March 2024 |
| Fact Sheet (March 2024) | Fact sheet | 2 slides | March 2024 |
| Q3 2023 Earnings Presentation | Earnings | 21 slides | Nov 15, 2023 |
| Q3 2023 Earnings Presentation | Earnings | 17 slides | Nov 15, 2023 |
| H1 2023 Earnings Presentation | Earnings | 28 slides | Aug 29, 2023 |
| Q1 2023 Earnings Presentation | Earnings | 19 slides | May 15, 2023 |
| Q1 2023 Earnings Presentation | Earnings | 16 slides | May 15, 2023 |
| Investor Day (November 2022) | Investor day | 48 slides | Nov 22, 2022 |
| H1 2022 Earnings Presentation | Earnings | 18 slides | Sep 7, 2022 |
| Q1 2022 Earnings Presentation | Earnings | 18 slides | May 18, 2022 |
| Q1 2022 Earnings Presentation | Earnings | 14 slides | May 18, 2022 |
| FY2021 Earnings Presentation | Earnings | 21 slides | Apr 12, 2022 |
| Investor Day (2022) | Investor day | 29 slides | 2022 |
| Investor Day (2022) | Investor day | 15 slides | 2022 |
| Investor Day (2022) | Investor day | 35 slides | 2022 |
| Q3 2021 Earnings Presentation | Earnings | 17 slides | Nov 16, 2021 |
| H1 2021 Earnings Presentation | Earnings | 17 slides | Sep 7, 2021 |
| Shareholder Meeting (June 2021) | Shareholder meeting | 27 slides | Jun 23, 2021 |
| Q1 2021 Earnings Presentation | Earnings | 17 slides | May 18, 2021 |
| FY2020 Earnings Presentation | Earnings | 22 slides | Apr 13, 2021 |
| Q3 2020 Earnings Presentation | Earnings | 17 slides | Nov 16, 2020 |
| H1 2020 Earnings Presentation | Earnings | 17 slides | Sep 9, 2020 |
| Shareholder Meeting (June 2020) | Shareholder meeting | 20 slides | Jun 17, 2020 |
| Q1 2020 Earnings Presentation | Earnings | 17 slides | May 19, 2020 |
| FY2019 Earnings Presentation | Earnings | 22 slides | Apr 8, 2020 |
| Q3 2019 Earnings Presentation | Earnings | 14 slides | Nov 20, 2019 |
| H1 2019 Earnings Presentation | Earnings | 16 slides | Sep 12, 2019 |
| Shareholder Meeting (June 2019) | Shareholder meeting | 25 slides | Jun 4, 2019 |
| Q1 2019 Earnings Presentation | Earnings | 16 slides | May 21, 2019 |
| FY2018 Earnings Presentation | Earnings | 22 slides | Apr 17, 2019 |
| Q3 2018 Earnings Presentation | Earnings | 23 slides | Nov 20, 2018 |
| H1 2018 Earnings Presentation | Earnings | 22 slides | Sep 12, 2018 |
| Shareholder Meeting (June 2018) | Shareholder meeting | 34 slides | Jun 26, 2018 |
This page holds 50 of 51 decks. Open Decks
Financials
Annual, in EUR
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.16B | 1.18B | 1.14B | 1.02B | 942.9M | 793.8M | 700.9M | 572.4M | 467.1M | 444.5M |
| Cost of revenue | 773.3M | 413.7M | 416.2M | 363.9M | 322.2M | 330.3M | 317.2M | 272.7M | 245.6M | 243.4M |
| Gross profit | 391.7M | 767.1M | 719.2M | 660.8M | 620.7M | 463.5M | 383.7M | 299.8M | 221.5M | 201.0M |
| Research and development | 11.2M | 11.5M | 10.6M | 13.2M | 14.2M | 12.7M | 11.2M | 6.96M | 6.64M | 4.82M |
| Selling, general and administrative | 13.2M | 13.6M | 20.2M | 16.1M | 13.1M | 14.7M | 12.7M | 9.83M | 6.93M | 3.25M |
| Operating income | 221.7M | 216.9M | 182.9M | 243.7M | 298.5M | 136.9M | 119.5M | 107.5M | 92.1M | 86.8M |
| Depreciation and amortization | 92.6M | 86.8M | 104.6M | 94.9M | 55.2M | 47.4M | 47.9M | 24.1M | 16.2M | 14.1M |
| EBITDA | 314.3M | 303.7M | 287.5M | 338.6M | 353.6M | 184.3M | 167.4M | 131.6M | 108.3M | 100.9M |
| Interest expense | 52.7M | 58.4M | 59.5M | 13.9M | 9.85M | 10.6M | 10.9M | 7.57M | 7.55M | 9.69M |
| Income before tax | 183.5M | 172.0M | 106.0M | 216.3M | 293.0M | 125.3M | 110.1M | 104.2M | 88.0M | 82.9M |
| Income tax | 52.2M | 60.3M | 45.5M | 83.7M | 84.1M | 39.4M | 32.3M | 29.0M | 10.3M | 5.87M |
| Net income | 132.4M | 113.8M | 62.4M | 134.2M | 209.6M | 85.8M | 77.2M | 75.3M | 77.7M | 16.8M |
| Earnings per share, basic | 2.46 | 2.11 | 1.16 | 2.49 | 3.89 | 1.59 | 1.43 | 1.41 | 1.44 | 0.31 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 203.4M | 121.2M | 158.7M | 149.9M | 160.3M | 120.6M | 115.0M | 212.8M | 6.29M | 3.82M |
| Short-term investments | 735.0K | 511.0K | 818.0K | 11.4M | 11.7M | 1.04M | 1.06M | 1.10M | 400.0K | 30.0K |
| Receivables | 121.4M | 105.0M | 95.4M | 100.1M | 76.1M | 55.5M | 53.0M | 34.1M | 102.6M | 66.2M |
| Inventory | 328.7M | 339.9M | 320.8M | 251.8M | 240.5M | 203.3M | 172.2M | 115.6M | 81.1M | 84.6M |
| Current assets | 702.9M | 593.5M | 630.5M | 533.9M | 519.2M | 400.1M | 352.9M | 371.2M | 192.9M | 157.0M |
| Property, plant and equipment | 318.5M | 315.0M | 330.8M | 225.7M | 222.3M | 199.6M | 132.6M | 80.9M | 56.0M | 53.4M |
| Goodwill | 587.1M | 576.4M | 578.5M | 271.3M | 264.7M | 266.3M | 202.2M | 54.6M | 24.6M | 17.0M |
| Total assets | 2.20B | 2.08B | 2.16B | 1.41B | 1.41B | 1.22B | 1.04B | 704.6M | 415.3M | 311.7M |
| Accounts payable | 96.3M | 94.8M | 86.6M | 56.1M | 52.1M | 50.4M | 35.4M | 28.2M | 23.4M | 24.5M |
| Current liabilities | 342.9M | 326.9M | 394.5M | 217.8M | 155.6M | 132.9M | 102.4M | 146.4M | 80.6M | 115.4M |
| Long-term debt | 904.1M | 877.3M | 950.7M | 501.8M | 565.7M | 570.5M | 533.6M | 232.6M | 222.3M | 96.8M |
| Total debt | 1.05B | 979.6M | 1.08B | 516.4M | 580.3M | 606.8M | 554.6M | 304.3M | 254.7M | 162.8M |
| Total liabilities | 1.50B | 1.47B | 1.62B | 880.3M | 907.1M | 899.8M | 760.4M | 448.5M | 341.6M | 250.9M |
| Shareholders' equity | 694.4M | 604.4M | 539.2M | 531.6M | 497.3M | 322.0M | 278.6M | 252.4M | 73.7M | 56.9M |
| Shares outstanding | 53.8M | 53.8M | 53.8M | 53.8M | 53.8M | 53.8M | 53.8M | 53.4M | 53.8M | 53.8M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 181.5M | 201.4M | 219.4M | 288.5M | 250.4M | 131.1M | 100.6M | 159.1M | 86.7M | 76.8M |
| Capital spending | -42.1M | -38.2M | -41.5M | -39.0M | -61.2M | -40.8M | -46.4M | -26.0M | -74.7M | -17.8M |
| Free cash flow | 139.4M | 163.1M | 177.9M | 249.5M | 189.2M | 90.3M | 54.2M | 133.2M | 12.0M | 59.0M |
| Cash from investing | -110.0M | -29.6M | -415.4M | -99.0M | -129.3M | -105.9M | -382.2M | -110.0M | -84.9M | -12.3M |
| Cash from financing | 13.3M | -209.2M | 204.5M | -199.8M | -81.0M | -14.1M | 184.0M | 164.4M | -7.98M | -55.9M |
| Dividends paid | -48.5M | -47.4M | -56.5M | -116.8M | -47.4M | -43.1M | -41.5M | -41.5M | -41.5M | -41.5M |
| Share buybacks | 0 | 107.5M | 120.0K | 120.0K | ||||||
| Change in cash | 82.1M | -37.4M | 7.70M | -10.4M | 41.1M | 11.3M | -97.4M | 213.6M | -6.15M | 8.59M |
Cap table
Built by 6ix from Dermapharm Holding SE’s releases
- Common shares
- 49,540,810
- Fully diluted
- 49,540,810
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 49,540,810 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 49,540,810 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Britta Hamberger | Investor Relations & Corporate Communications · Since at least Aug 25, 2026 |
| Dermapharm Holding SE | ir.dermapharm.de · Since at least Aug 25, 2026 |
Log in to ask 6ix AI your own questions about Dermapharm Holding SE.